First Time Loading...

ABVC Biopharma Inc
NASDAQ:ABVC

Watchlist Manager
ABVC Biopharma Inc Logo
ABVC Biopharma Inc
NASDAQ:ABVC
Watchlist
Price: 1.08 USD -6.09% Market Closed
Updated: May 5, 2024

ABVC Biopharma Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ABVC Biopharma Inc
Revenue Peer Comparison

Comparables:
AMGN
ALNY
KRTX
MRNA
SRPT

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
ABVC Biopharma Inc
NASDAQ:ABVC
Revenue
$152.4k
CAGR 3-Years
-32%
CAGR 5-Years
72%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Revenue
$1.8B
CAGR 3-Years
55%
CAGR 5-Years
89%
CAGR 10-Years
44%
Karuna Therapeutics Inc
NASDAQ:KRTX
Revenue
$654k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Moderna Inc
NASDAQ:MRNA
Revenue
$6.8B
CAGR 3-Years
104%
CAGR 5-Years
119%
CAGR 10-Years
N/A
Sarepta Therapeutics Inc
NASDAQ:SRPT
Revenue
$1.4B
CAGR 3-Years
35%
CAGR 5-Years
34%
CAGR 10-Years
57%

See Also

What is ABVC Biopharma Inc's Revenue?
Revenue
152.4k USD

Based on the financial report for Dec 31, 2023, ABVC Biopharma Inc's Revenue amounts to 152.4k USD.

What is ABVC Biopharma Inc's Revenue growth rate?
Revenue CAGR 5Y
72%

Over the last year, the Revenue growth was -84%. The average annual Revenue growth rates for ABVC Biopharma Inc have been -32% over the past three years , 72% over the past five years .